Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine being tested for use in the age group of 2-18 yrs - is also likely to get a go-ahead by September. August 20, 2021 at 02:15AM India News | Latest News Headlines & Live Updates from India - Times of IndiaCovid vaccination for kids may start only by March ’22

Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine being tested for use in the age group of 2-18 yrs - is also likely to get a go-ahead by September.

from India News | Latest News Headlines & Live Updates from India - Times of India